GlobeNewsWire
06 Aug 2026, 21:38 UTC · 2h ago
BioStem Technologies Announces Nasdaq Uplisting
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
GlobeNewsWire
06 Aug 2026, 21:38 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
BioStem Technologies has been approved by Nasdaq to uplist its common stock from the OTC market to the Nasdaq Capital Market. — Uplisting to a major exchange typically increases institutional ownership, liquidity, and perceived company credibility.
+0.60Trading of BioStem Technologies (BSEM) on the Nasdaq is expected to commence on August 7, 2026. — Provides a concrete timeline for the transition in trading venue and liquidity profile.
+0.30The company expects the uplisting to expand its access to capital and improve its ability to attract talent. — Suggests potential for future funding rounds and operational scaling, though these are forward-looking expectations.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company is uplisting from OTC to Nasdaq, which is expected to improve liquidity, visibility, and access to capital.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
4h ago
